Effects of immunomodulatory agents on patch testing: Expert opinion 2012

Dermatitis

Volumn 23, Issue 6, 2012, Pages 301-303

  Fowler, Joseph F ^a   Maibach, Howard I ^b   Zirwas, Matthew ^c   Taylor, James S ^d   DeKoven, Joel G ^e   Sasseville, Denis ^f   Warshaw, Erin M ^g   Belsito, Donald V ^h   Storrs, Frances J ⁱ   Zug, Kathryn A ^j   Pratt, Melanie D ^k   Mathias, C G Toby ^l   DeLeo, Vincent A ^h   Fransway, Anthony F ^m   Marks, James G ⁿ  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^f ROYAL VICTORIA HOSPITAL   (Canada)

^g UNIVERSITY OF MINNESOTA   (United States)

^h Och Spine at New York Presbyterian Hospitals   (United States)

ⁱ OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^j DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^k UNIVERSITY OF OTTAWA   (Canada)

^l UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^m Pennsylvania State University ^*

ⁿ PENN STATE COLLEGE OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; CALCINEURIN; CORTICOSTEROID; CYCLOSPORIN A; ETANERCEPT; FORMALDEHYDE; GOLIMUMAB; IMMUNOMODULATING AGENT; INFLIXIMAB; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PREDNISONE; TACROLIMUS; TRIAMCINOLONE ACETONIDE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; USTEKINUMAB;

CONSENSUS; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG WITHDRAWAL; FALSE NEGATIVE RESULT; HEALTH SURVEY; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; LETTER; LOW DRUG DOSE; OINTMENT; PATCH TEST; PRACTICE GUIDELINE; PRIORITY JOURNAL; RELIABILITY; ULTRAVIOLET RADIATION;

EID: 84871281744     PISSN: 17103568     EISSN: None     Source Type: Journal    
DOI: 10.1097/DER.0b013e318275969f     Document Type: Letter

References (5)

1. Wee J, White J, McFadden J, et al. Patch testing in patients treated with systemic immunosuppression and cytokine inhibitors. Contact Dermatitis 2010;62:165-169.
2. Rosmarin D, Gottlieb A, Asarch A, et al. Patch-testing while on systemic immunosuppressants. Dermatitis 2009;20:265-270.
3. Anveden I, Lindberg M, Andersen K, et al. Oral prednisone suppresses allergic but not irritant patch test reactions in individuals hypersensitive to nickel. Contact Dermatitis 2004;50:298-303.
4. Condie M, Adams R. Influence of oral prednisone on patch-test reactions with Rhus antigen. Arch Dermatol 1973;107:540-643.
5. Clark R, Rietschel R. The effect of triamcinolone acetonide ointment 0.1% on positive patch tests. Arch Dermatol 1982;118:163-165.